rdkriplani

Natco Pharma - Bottoming Out

NSE:NATCOPHARM   NATCO PHARMA LTD
Potentially the stock has bottomed out..the management has guided for big earnings going ahead and actively looking for an acquisition based off those earnings.
Technically the stock has been consolidating in the 625-650 range and now there is a double divergence on the RSI as well. The stock is also as close to a channel bottom as possible

Long at current prices with stploss below 600.

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。